Be sure residents, visitors, and facility staff are tested and safe from COVID-19—now possible with the Salus mobile solution. This suite of mobile apps and testing methodology prevents the threat of coronavirus from reaching our community's most vulnerable population.
Salus is a fully-HIPAA-compliant solution designed by a team of medical and technology experts.
Rapid testing can take place at the facility, ideal for daily access. Users can be tested at a third-party location of their choice before their visit to the facility.
• Staff, etc.
For staff and volunteers at Salus-protected assisted care facilities. Similar to Salus Access, staff and volunteers use their Salus Employee profile to scan their QR code into Salus Monitor. Supervisors will be able to check records within the Salus Monitor dashboard to ensure their staff is COVID-19 free.
Salus works with a multitude of third-party, certified testing providers nationwide. The Salus solution is agnostic of the type of COVID-19 testing and can accept test results from PCR, Rapid Assurance Antigen, Rapid Antibody, and eventually vaccine results. Approved testing providers can download the Salus Test app from the Apple or Google Play app store.
COVID-19 tests fall into three main categories: PCR, antigen, and antibody. Most COVID-19 testing done thus far has been polymerase chain reaction (PCR). These tests detect disease by looking for traces of the virus’ genetic material via a sample collected typically from a nose or throat swab, although some PCR tests use a saliva sample. Rapid Assurance Antigen tests can turn around results in as little time as 15 minutes and, like PCR tests, require a throat or nasal swab. Unlike PCR tests, Rapid Assurance Antigen tests look for proteins that live on the surface of the virus. Rapid Antibody tests are not meant to identify a current infection, rather they search the blood for antibodies, proteins produced in response to an infection that may provide limited immunity against the COVID-19 virus in the future.
Unlike checking for high body temperature—which may identify if someone is showing symptoms of COVID-19—testing identifies people who are COVID-19 asymptomatic and symptomatic/pre-symptomatic, resulting in much greater levels of risk mitigation and increased safety.
The current scientific medical data indicates that results are valid for a 70-80 hour period, as this is the average time it takes from first being infected with COVID-19 to being contagious. Note, the average time for a symptomatic COVID-19 carrier to show symptoms is 5.2 days after being infected. (Source: https://www.acpjournals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported)
The testing center that administers the COVID-19 test maintains the storage and security of the patient data. Salus and the venue do not have access to patient data; only that the user is COVID-19 negative and has a valid QR code to attest to that.
Doug is responsible for working with the executive and business development team in bringing OZ's Salus solution to market. He leads OZ's business development efforts and is single-minded in finding ways to provide his clients with the right solutions to solve the challenges they face in dealing with the challenges associated with the COVID-19 pandemic.
He has 20+ years of experience advising companies in the technology, professional services, and manufacturing space on business development, customer experience, and leadership best practices. Doug is the company’s spokesperson, and key point of contact for COVID-19 test manufacturers, having developed relationships with multiple international providers.
Previously, Doug was one of the founders of a company in the litigation consulting space, which grew over 17 years from three employees to over 300, and was successfully sold to a 55,000 employee public company. He is a frequent national speaker on business development, communications, customer experience, and leadership best practices.